Shares of Teladoc Health slumped after the company logged a wider fourth-quarter loss than analysts had expected and provided tepid guidance for 2025. The stock was down 18% at $9 in early trading.
Teladoc Health reported weak fourth-quarter results as challenges in its BetterHelp segment weighed down gains elsewhere in ...
Elanco Animal Health narrowed its fourth-quarter loss despite lower sales, but its forecast for the current quarter and full year came in below Wall Street's estimates.
Stocks were lower Wednesday, giving up earlier gains, putting the S&P 500 on pace for a fifth straight day of losses.
Data delayed at least 15 minutes Source: FactSet By The New York Times By Joe Rennison Stocks slumped on Friday, with the S&P 500 wiping out almost all of its gains since President Trump took ...
The oncology testing specialist reported strong top-line growth, but also rising costs and ongoing net losses.
Revenue for the Atlanta company climbed to $39.7 billion from $34.79 billion. Analysts polled by FactSet were calling for $39 ...
Our fair value estimate for Iress is AUD 9.00 per share. Our discounted cash flow valuation assumes a weighted average cost of capital of 9%.
Financial Health for FactSet Research is determined by ranking the company on over 100 factors against companies in the Financials sector and operating in Developed economic markets. Loading view data ...
Pending home sales in the United States slid to an all-time low in January as high mortgage rates, record-high home prices, ...
The fitness center chain is guiding for another 10% revenue increase this year after higher royalty revenue and new club ...